Cargando…

Risk-Stratified Treatment in Chronic Lymphocytic Leukemia

Detalles Bibliográficos
Autores principales: Stephens, Deborah M., Goodrich, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679049/
https://www.ncbi.nlm.nih.gov/pubmed/29152397
_version_ 1783277546532503552
author Stephens, Deborah M.
Goodrich, Amy L.
author_facet Stephens, Deborah M.
Goodrich, Amy L.
author_sort Stephens, Deborah M.
collection PubMed
description
format Online
Article
Text
id pubmed-5679049
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-56790492017-11-18 Risk-Stratified Treatment in Chronic Lymphocytic Leukemia Stephens, Deborah M. Goodrich, Amy L. J Adv Pract Oncol Review Article Harborside Press 2016-04 2016-04-01 /pmc/articles/PMC5679049/ /pubmed/29152397 Text en Copyright © 2016, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Stephens, Deborah M.
Goodrich, Amy L.
Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title_full Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title_fullStr Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title_full_unstemmed Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title_short Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
title_sort risk-stratified treatment in chronic lymphocytic leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679049/
https://www.ncbi.nlm.nih.gov/pubmed/29152397
work_keys_str_mv AT stephensdeborahm riskstratifiedtreatmentinchroniclymphocyticleukemia
AT goodrichamyl riskstratifiedtreatmentinchroniclymphocyticleukemia